We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.
TODAY'S HIGH
144.9
TODAY'S LOW
140.5
52 WEEK HIGH
196.95
52 WEEK LOW
95.5
% of Shares Held by
All Insider
51.45%
% of Shares Held by
Institutions
0.00%
% of Float Held by
Institutions
0.00%
Number of Institutions
Holding Shares
0
MARKET CAP
227.60 Cr.
ETERPRISE VALUE
307.89 Cr.
NO. OF SHARES
1.58 Cr.
BOOK VALUE
95.177
DIV. YIELD
0.5%
DEBT
87.90 Cr.
GROSS PROFIT
140.92 Cr.
CASH
1.95 Cr.
REVENUE
447.56 Cr.
REVENUE/SHARE
282.778
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 20.71 Lakhs | 20.71 Lakhs | 1.66 Lakhs | 1.66 Lakhs |
| Change To Liabilities | 11.15 Cr. | -13.91 Cr. | 24.17 Cr. | -5.21 Cr. |
| Total cashflows from Investing Activities | -27.32 Cr. | -31.28 Cr. | -6.87 Cr. | -9.25 Cr. |
| Net Borrowings | 9.15 Cr. | 12.02 Cr. | -13.07 Cr. | -2.79 Cr. |
| Total Cash from Financing Activities | -2.01 Cr. | 2.69 Cr. | -23.47 Cr. | -11.43 Cr. |
| Other Liabilities | 28.94 Cr. | 1.32 Cr. | -4.79 Cr. | 2.16 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 19.65 Cr. | 27.97 Cr. | 8.25 Cr. | -8.03 Cr. |
| Change in Cash | 1.36 Cr. | -1.03 Cr. | 19.58 Lakhs | 1 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 30.69 Cr. | 27.54 Cr. | 30.54 Cr. | 21.69 Cr. |
| Depreciation | 10.24 Cr. | 8.63 Cr. | 8.21 Cr. | 7.51 Cr. |
| Other Cashflows from Investing Activities | 5 k | 5 k | 4 k | 2.01 Lakhs |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | -58.51 Cr. | 6.25 Cr. | 8.61 Cr. | -13.31 Cr. |
| Change to Account Receivables | 7.82 Cr. | -13.60 Cr. | -22.35 Cr. | 27.57 Cr. |
| Other Cashflows from Financing Activities | -11.16 Cr. | -9.32 Cr. | -10.40 Cr. | -8.64 Cr. |
| Change to Net Income | 11.39 Cr. | 10.34 Cr. | 8.43 Cr. | 10.99 Cr. |
| Capital Expenditures | -27.66 Cr. | -31.43 Cr. | -6.93 Cr. | -9.33 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 27.73 Cr. | 39.51 Cr. | 6.25 Cr. | -5.73 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 35.29 Cr. | 44.55 Cr. | 15.80 Cr. | 2.79 Cr. |
| Selling General Administrative | 37.25 Cr. | 30.49 Cr. | 27 Cr. | 26.57 Cr. |
| Gross Profit | 140.92 Cr. | 124.51 Cr. | 84.66 Cr. | 71.45 Cr. |
| Ebit | 35.29 Cr. | 44.55 Cr. | 15.80 Cr. | 2.79 Cr. |
| Operating Income | 35.29 Cr. | 44.55 Cr. | 15.80 Cr. | 2.79 Cr. |
| Other Operating Expenses | 58.12 Cr. | 40.29 Cr. | 33.62 Cr. | 34.99 Cr. |
| Interest Expense | -11.16 Cr. | -6.32 Cr. | -6.49 Cr. | -6.61 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 8.07 Cr. | 11.54 Cr. | -2 Cr. | 2.29 Cr. |
| Total Revenue | 447.56 Cr. | 380.14 Cr. | 282.35 Cr. | 227.57 Cr. |
| Total Operating Expenses | 412.26 Cr. | 335.58 Cr. | 266.54 Cr. | 224.78 Cr. |
| Cost of Revenue | 306.63 Cr. | 255.62 Cr. | 197.69 Cr. | 156.12 Cr. |
| Total Other Income Expense Net | -7.56 Cr. | -5.03 Cr. | -9.55 Cr. | -8.53 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 19.65 Cr. | 27.97 Cr. | 8.25 Cr. | -8.03 Cr. |
| Net Income Applicable to Common Shares | 19.65 Cr. | 27.97 Cr. | 8.25 Cr. | -8.03 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 13.87 Cr. | 8.47 Cr. | 6.13 Cr. | 3.76 Cr. |
| Capital Surplus | 0 | 22.37 Cr. | 22.37 Cr. | 22.37 Cr. |
| Total Liabilities | 177.86 Cr. | 131.88 Cr. | 126.72 Cr. | 115.69 Cr. |
| Stock Holder Equity | 150.56 Cr. | 130.96 Cr. | 103.93 Cr. | 95.66 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 14.70 Cr. | 1.75 Cr. | 1.88 Cr. | 28.78 Lakhs |
| Total Assets | 328.42 Cr. | 262.84 Cr. | 230.66 Cr. | 211.35 Cr. |
| Common Stock | 15.82 Cr. | 15.82 Cr. | 15.82 Cr. | 15.82 Cr. |
| Retained Earnings | 0 | 93.30 Cr. | 65.33 Cr. | 57.07 Cr. |
| Other Liabilities | 17.43 Cr. | 14.17 Cr. | 12.28 Cr. | 14.33 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 134.73 Cr. | -54.44 Lakhs | 40.34 Lakhs | 38.01 Lakhs |
| Other Assets | 5.28 Cr. | 6.30 Cr. | 8.95 Cr. | 2.38 Cr. |
| Cash | 1.95 Cr. | 59.18 Lakhs | 1.62 Cr. | 1.43 Cr. |
| Current Liabilities | 135.10 Cr. | 107.64 Cr. | 109.46 Cr. | 90.81 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 11.60 Cr. | 5.90 Cr. | 4 Cr. | 3.78 Cr. |
| Other Stockholder Equity | 134.73 Cr. | -54.44 Lakhs | 40.34 Lakhs | 38.01 Lakhs |
| Property Plant Equipment | 126.79 Cr. | 115.87 Cr. | 96.17 Cr. | 99.92 Cr. |
| Total Cur. Assets | 182.46 Cr. | 131.97 Cr. | 119.17 Cr. | 105.03 Cr. |
| Long Term Investments | 43 k | 22.35 Lakhs | 22.35 Lakhs | 24.01 Lakhs |
| Net Tangible Assets | 136.68 Cr. | 122.48 Cr. | 97.80 Cr. | 91.89 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 46.52 Cr. | 53.60 Cr. | 39.99 Cr. | 17.63 Cr. |
| Long Term Debt | 20.11 Cr. | 6.87 Cr. | 4.17 Cr. | 8.59 Cr. |
| Inventory | 117.10 Cr. | 58.58 Cr. | 64.84 Cr. | 73.45 Cr. |
| Accounts Payable | 54.54 Cr. | 42.67 Cr. | 56.59 Cr. | 32.41 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account